TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
公司代码TMDX
公司名称Transmedics Group Inc
上市日期May 02, 2019
CEOHassanein (Waleed H)
员工数量728
证券类型Ordinary Share
年结日May 02
公司地址200 Minuteman Road
城市ANDOVER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编01810
电话19785520900
网址https://www.transmedics.com/
公司代码TMDX
上市日期May 02, 2019
CEOHassanein (Waleed H)